tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Andrew Tsai - 24 which are a Buy (88.89%), 3 which are a Hold (11.11%)
Analyst Andrew Tsai works at JEFFERIES and is covering the Healthcare sector with 56 price targets and ratings displayed on 8 stocks.
Andrew Tsai's average stock forecast success ratio is 32.08% with an average time for price targets to be met of 208 days.
Most recent stock forecast was given on RLMD, at 13-Oct-2022.
Analyst best performing recommendations are on XENE (XENON PHARMACEUTICALS).
The best stock recommendation documented was for XENE (XENON PHARMACEUTICALS) at 8/30/2021. The price target of $28 was fulfilled within 35 days with a profit of $11.09 (65.58%) receiving and performance score of 18.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
19
$16.95 (826.83%)
1 months 10 days ago
0/1 (0%)
$16.19 (576.16%)
Buy
5
$2.95 (143.90%)
6
4 months 6 days ago
0/3 (0%)
$2.83 (56.65%)
Buy
10
$7.95 (387.80%)
33
5 months 22 days ago
0/2 (0%)
$15.64 (281.25%)
Buy
3
$0.95 (46.34%)
32
1 years 2 months 29 days ago
1/3 (33.33%)
$15.96 (136.63%)
7
Buy
5
$2.95 (143.90%)
1 years 2 months 29 days ago
0/1 (0%)
$2.25 (81.82%)
What Year was the first public recommendation made by Andrew Tsai?
